New Jersey Corporate Practice of Medicine: A Complete Compliance Guide

New Jersey is one of the most challenging states in the country for healthcare startup compliance — and one of the most frequently underestimated. Founders often assume that because New Jersey lacks a single, explicitly titled "CPOM statute," the state must be flexible. The opposite is true. New Jersey's corporate practice of medicine doctrine is aggressively enforced through a combination of the Medical Practice Act, Attorney General opinions, and a State Board of Medical Examiners that actively investigates non-compliant arrangements. If you are building a digital health company, a telehealth platform, or a multi-state medical group that includes New Jersey, you need to understand this state's rules in detail before you structure your entity.

The Legal Foundation: No Single Statute, but Rock-Solid Doctrine

New Jersey's prohibition on corporate practice of medicine does not rest on a single statute the way some states have codified the doctrine. Instead, it emerges from the New Jersey Medical Practice Act (N.J.S.A. 45:9-1 et seq.), which restricts the practice of medicine to licensed individuals, and the Professional Service Corporation Act (N.J.S.A. 14A:17-1 et seq.), which governs how professional corporations must be structured. These statutes, combined with a series of authoritative Attorney General opinions and case law, have created a doctrine that is well-established and strictly interpreted.

The New Jersey State Board of Medical Examiners has made clear through guidance and enforcement actions that a lay corporation — including an LLC, C-corp, or any non-professional entity — cannot employ physicians for the purpose of practicing medicine, cannot direct clinical decision-making, and cannot receive a share of fees generated by the practice of medicine in a way that constitutes fee-splitting. These prohibitions apply regardless of how the underlying contracts are labeled.

New Jersey's lack of an explicit CPOM statute is not a loophole. The doctrine is deeply embedded in Board policy, AG opinions, and decades of enforcement. Treating it as ambiguous is one of the most common and costly mistakes healthcare founders make in this state.

Enforcement: Who Investigates and What They Look For

The New Jersey State Board of Medical Examiners is the primary enforcement body for CPOM violations. The Board has broad authority to investigate complaints, subpoena records, and discipline licensed physicians whose practices are not properly structured. Physicians who allow non-physician entities to control their clinical practice — even indirectly through restrictive management agreements — risk license suspension or revocation.

The New Jersey Attorney General's Office also plays a role. The AG can seek injunctive relief to shut down unlicensed medical practice and can pursue civil penalties against entities operating outside the law. Historically, the AG has acted against medical spas, cosmetic procedure centers, and telehealth companies that were structured in ways that permitted lay control of clinical operations.

Enforcement in New Jersey is more common than founders expect. The Board does not wait for patient complaints to initiate investigations — it responds to competitor complaints, insurance audits, billing irregularities, and tips from physicians who were approached about improper arrangements. Private equity firms doing roll-up transactions in New Jersey have found the state particularly unforgiving when acquiring practices without adequate legal review.

What Triggers an Investigation

• A management agreement that gives the MSO authority to override clinical protocols or set treatment guidelines
• Employment contracts where a lay entity — not the PC — employs the physicians
• Physician compensation that is directly tied to revenue metrics in a way that could influence prescribing
• A practice where the physician-owner cannot demonstrate actual involvement in clinical governance
• Billing arrangements where a non-physician entity is listed as the billing entity for medical services
• Marketing and intake functions controlled entirely by the MSO without any clinical oversight by the PC

The Domestic PC Requirement: A New Jersey-Specific Trap

This is the rule that catches the most founders by surprise. New Jersey is one of a small number of states that requires a domestic professional corporation — meaning one incorporated under New Jersey law — to operate a medical practice in the state. You cannot take a professional corporation formed in Delaware, Wyoming, or any other state, register it as a foreign entity in New Jersey, and use it to operate a New Jersey medical practice.

This matters enormously for multi-state platform companies. Many founders launch in California or Texas with a professional corporation formed in those states, then attempt to expand to New Jersey by simply registering that existing PC as a foreign corporation. That approach does not satisfy New Jersey's requirement. You must form a separate New Jersey professional corporation under the New Jersey Professional Service Corporation Act, with at least one shareholder who holds a valid New Jersey physician license.

The domestic PC requirement also affects how you structure ownership and governance when operating across multiple states. The New Jersey PC cannot simply be a subsidiary of a parent PC in another state — it must be a standalone entity owned by a New Jersey-licensed physician. For founders managing a network of state-level PCs, New Jersey means you need a dedicated NJ entity and a dedicated NJ physician-owner, not a shared structure borrowed from another state.

The MSO-PC Structure in New Jersey

Despite the strict rules, New Jersey does permit the Management Services Organization / Professional Corporation model, and it is the standard compliance vehicle for non-physician founders in the state. The structure works as follows:

How to Build a Compliant Structure

• Form a New Jersey professional corporation under N.J.S.A. 14A:17-1 et seq., with 100% ownership held by a New Jersey-licensed physician (the "friendly PC owner"). The PC is the entity that employs or contracts with clinical providers and bills for medical services.
• Form the MSO as a New Jersey LLC or a properly registered out-of-state entity. The MSO is owned by the founders and/or investors and provides all non-clinical management services: billing and coding support, technology, marketing, HR administration, real estate, and supplies.
• Execute a Management Services Agreement (MSA) between the MSO and the PC. The MSA governs what services the MSO provides, the compensation structure, and the division of clinical versus non-clinical authority.
• Ensure the management fee reflects fair market value. New Jersey regulators scrutinize MSA fee structures closely. If the MSO's management fee is set at a percentage of the PC's revenue in a way that effectively transfers most revenue to the lay entity, this raises fee-splitting concerns. Fair market value documentation — ideally from an independent healthcare valuation firm — is essential.

Clinical Autonomy Is Non-Negotiable

The New Jersey PC owner must exercise genuine clinical authority. This is not a paperwork exercise. The physician-owner should be involved in setting clinical protocols, overseeing quality assurance processes, credentialing decisions, and physician supervision. Courts and regulators look at the substance of the arrangement, not just what the MSA says on paper. A physician who attests that they are "in charge" but who cannot describe the clinical governance processes of their practice will not survive scrutiny.

Fee-Splitting: A Distinct New Jersey Concern

New Jersey's fee-splitting prohibition under N.J.S.A. 45:9-22.1 is separate from the CPOM doctrine but interacts with it closely. The statute prohibits a licensed physician from dividing, sharing, or splitting fees with any person in exchange for the referral of patients. This provision has been broadly interpreted to apply to management fee arrangements that are structured in ways that effectively convert them into referral fees or revenue shares.

For digital health founders, this means that an MSA that compensates the MSO with a percentage of the PC's gross or net revenue — particularly if that revenue is variable based on patient volume — must be carefully structured and documented to avoid looking like a disguised referral arrangement. Flat management fees or fees tied to clearly defined service deliverables are generally safer than open-ended revenue percentages. When a percentage-based structure is commercially necessary, it should be accompanied by a robust FMV analysis and clear documentation that the fee reflects the value of services rendered rather than referral volume.

What Digital Health and Telehealth Founders Specifically Need to Know

New Jersey is a significant telehealth market — it has a large, densely populated base of patients accustomed to on-demand digital services, and the state has expanded telehealth coverage requirements under legislation passed in the wake of the COVID-19 public health emergency. However, the state's telehealth expansion has not relaxed CPOM rules in any meaningful way.

Several issues are particularly acute for digital health companies operating in New Jersey:

• Platform-as-employer trap. If your platform "employs" clinicians and routes them to patients — even asynchronously — and you are not structured with a proper NJ domestic PC as the employer of record, you are operating outside the law. The technology wrapper does not change the regulatory analysis.
• Intake and prescribing workflows. If your technology platform is making clinical decisions — suggesting diagnoses, recommending treatments, or auto-populating prescriptions based on patient-entered data — you may be crossing into the unauthorized practice of medicine, separate from and in addition to any CPOM issue.
• Out-of-state physician networks. New Jersey requires that physicians treating New Jersey patients be licensed in New Jersey. Operating a platform that routes NJ patients to out-of-state physicians without NJ licenses is a licensing violation independent of CPOM, but enforcement of the two issues often arrives together.
• Investor control provisions. Venture-backed companies often include investor rights in operating agreements that give investors the right to approve or veto significant business decisions. If those provisions extend to the PC — even indirectly through a parent-subsidiary relationship — they can constitute lay control of a medical practice under New Jersey's CPOM doctrine. Carefully wall off all investor control rights from the PC's governance documents.

New Jersey CPOM Compliance Checklist

1. Form a domestic New Jersey professional corporation under the NJ Professional Service Corporation Act — do not use a foreign PC from another state.
2. Verify the PC owner holds a current, unrestricted New Jersey medical license — license status should be confirmed before closing any structuring transaction.
3. Draft a Management Services Agreement with clearly defined services, flat or FMV-based compensation, and explicit clinical autonomy protections for the physician-owner.
4. Obtain a fair market value analysis of the management fee from a qualified healthcare valuation firm, and update it annually or when scope of services changes.
5. Document the PC owner's clinical governance activities — meeting minutes, protocol approvals, credentialing decisions, and QA reviews should be maintained as contemporaneous records.
6. Review investor rights documents to ensure no control rights extend to the PC or its clinical operations.
7. Audit your billing arrangements — the PC, not the MSO or the technology platform, must be the billing entity for clinical services.
8. Ensure all physicians treating New Jersey patients hold valid NJ licenses and that your credentialing processes are managed by or under the oversight of the PC.
9. Review your platform's clinical decision support functions with healthcare counsel to confirm they do not constitute the practice of medicine.
10. Establish a compliance calendar for annual review of the MSA, management fee structure, and PC governance documentation.

The Cost of Getting It Wrong

The consequences of a CPOM violation in New Jersey are serious. A physician whose practice is found to be controlled by a lay entity can lose their license. The lay entity can be enjoined from operation and face civil penalties. Contracts that violate CPOM are void and unenforceable under New Jersey law — which means the MSO may not be able to recover management fees it has already earned if the arrangement is later found to be non-compliant. And for a venture-backed company, a CPOM finding can trigger representations and warranties claims from investors, complicate or kill an M&A exit, and generate negative press coverage that damages the brand.

New Jersey rewards founders who invest in proper structure early. The cost of forming a compliant NJ PC and executing a well-drafted MSA is a fraction of the cost of remediation, litigation, or license loss after enforcement action begins. If you are entering New Jersey, do it right from day one.